turkrazzi

Sign in Sign up

Good afternoon · 12 November, Thursday

8° Clear

USD 50.23 ▲0.01 EUR 55.89 ▼0.77 GBP 66.84 ▼0.85 CHF 60.53 ▼1.10

C CNBC · 23 h ago Follow Markets

CFTC investigates if Kalshi improperly self-certified event contracts

News of the probe comes after the CFTC ordered Kalshi to take down a sports-related "mention markets" back in August.

Read on cnbc.com

This story comes from CNBC's feed; the full article and all rights belong to the source.

0 1

#CFTC #Kalshi #event contracts

Comments (0)

No comments yet. Be the first to comment.

Sign in to write a comment.

Related news

C CNBC · 39 min ago

Markets

Jim Cramer's top 10 things to watch in the stock market Thursday

0 0 0

C CNBC · 50 min ago

Markets

Oil prices jump after Trump says no Iran deal needed: 'We've got their Strait'

0 0 0

C CNBC · 1 h ago

Markets

‘A dark day for Nvidia’: Here’s what analysts are saying as markets brace for news on Huang's fate

0 0 0

C CNBC · 2 h ago

Markets

Cramer's stance on Nvidia's stock amid reports that CEO Jensen Huang may be ousted

0 0 0

A Al Jazeera · 13 h ago

Markets

Nvidia shares plunge amid reports board to discuss CEO Huang’s future

0 0 0

C CNBC · 14 h ago

Markets

Jim Cramer says investors need to pay attention to CoreWeave. Here's why

0 0 0

C CNBC · 17 h ago

Markets

Costco is giving shareholders a big, early holiday gift. How to make sure you get it

0 0 0

A Al Jazeera · 17 h ago

Markets

Oil production nears pre-Iran war levels, OPEC says

0 0 0

C CNBC · 18 h ago

Markets

We're adding a chipmaker to our Bullpen watchlist and downgrading another name

0 0 0

C CNBC · 19 h ago

Markets

Apple's record run ignites options flurry — Watch Options Action live

0 0 0

C CNBC · 20 h ago

Markets

Bouncing Wynn Shares might be primed for the 'wheel strategy'

0 0 0

C CNBC · 20 h ago

Markets

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

0 0 0

C CNBC · 21 h ago

Markets

Jim Cramer's plan for our Intel position. Plus, a rotation loser to buy here

0 0 0

C CNBC · 1 d ago

Markets

Jim Cramer's top 10 things to watch in the stock market Wednesday

0 0 0

C CNBC · 1 d ago

Markets

Nvidia shares rebound 4% as Huang faces scrutiny ahead of earnings

0 0 0

C CNBC · 1 d ago

Markets

CoreWeave stock pops 16% after outlook raise eases AI slowdown concerns

1 0 0

S Sky News YouTube · 1 d ago

Markets

Nvidia's sell-off is getting worse as market value plummets

1 0 0

C CNBC · 1 d ago

Markets

Investors pivot to defensive stocks as markets enter a ‘state of alert’

0 0 0

C CNBC · 1 d ago

Markets

Singapore wants a bigger slice of the global gold market. Is it too late to the party?

0 0 0

C CNBC · 1 d ago

Markets

GE Vernova sellers have it all wrong — plus, why Fed rate hike odds are soaring

0 0 0

C CNBC · 1 d ago

Markets

Traders bet on a pop for Anthropic's historic IPO

1 0 0

CFTC investigates if Kalshi improperly self-certified event contracts

Comments (0)

Related news

Jim Cramer's top 10 things to watch in the stock market Thursday

Oil prices jump after Trump says no Iran deal needed: 'We've got their Strait'

‘A dark day for Nvidia’: Here’s what analysts are saying as markets brace for news on Huang's fate

Nebius handily beats Q3 revenue expectations but shares fall

Treasury yields edge higher as investors await fresh inflation and housing data

The world's super-rich are piling into alternative investments. Here's why

Cramer's stance on Nvidia's stock amid reports that CEO Jensen Huang may be ousted

Nvidia shares plunge amid reports board to discuss CEO Huang’s future

Jim Cramer says investors need to pay attention to CoreWeave. Here's why

Costco is giving shareholders a big, early holiday gift. How to make sure you get it

Oil production nears pre-Iran war levels, OPEC says

We're adding a chipmaker to our Bullpen watchlist and downgrading another name

Apple's record run ignites options flurry — Watch Options Action live

Bouncing Wynn Shares might be primed for the 'wheel strategy'

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Jim Cramer's plan for our Intel position. Plus, a rotation loser to buy here

Jim Cramer's top 10 things to watch in the stock market Wednesday

Nvidia shares rebound 4% as Huang faces scrutiny ahead of earnings

CoreWeave stock pops 16% after outlook raise eases AI slowdown concerns

Nvidia's sell-off is getting worse as market value plummets

Investors pivot to defensive stocks as markets enter a ‘state of alert’

Singapore wants a bigger slice of the global gold market. Is it too late to the party?

GE Vernova sellers have it all wrong — plus, why Fed rate hike odds are soaring

Traders bet on a pop for Anthropic's historic IPO